Results 1 to 10 of about 5,099,009 (221)

Mantle Cell Lymphoma Presenting with Acute Bilateral Ophthalmoplegia [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2017
A 72-year-old woman presented with acute onset of double vision, bilateral complete blepharoptosis, and nearly complete ophthalmoplegia. Orbital and brain magnetic resonance imaging were normal.
Yaran Koban   +6 more
doaj   +2 more sources

Magnetic resonance imaging with pathological correlation in a case of mantle cell lymphoma of the parotid gland: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction Mantle cell lymphoma is a rare non-Hodgkin's lymphoma. It is a subtype of B-cell lymphoma with frequent involvement of the bone marrow and the gastrointestinal tract. Isolated parotid gland involvement seldom occurs.
Karakozoglou Thrasivulos   +4 more
doaj   +1 more source

Mantle cell lymphoma of the larynx: Primary case report

open access: yesJournal of Medical Case Reports, 2012
Introduction Primary laryngeal lymphomas are exceedingly rare. Only about a hundred cases have been reported. They consist mainly of non-Hodgkin lymphoma, especially of diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue.
Naciri Sarah   +7 more
doaj   +1 more source

Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma

open access: yesHeliyon, 2019
IFI16, member of the IFN-inducible PYHIN-200 gene family, modulates proliferation, survival and differentiation of different cell lineages. In particular, IFI16 expression, which is regulated during the differentiation of B cells, was recently studied in
Pier Paolo Piccaluga   +13 more
doaj   +1 more source

Multiple lymphomatous polyposis: A presentation for mantle cell lymphoma

open access: yesClinical Case Reports, 2020
Multiple lymphomatous polyposis is an uncommon presentation of mantle cell lymphoma, and when exhibited should prompt clinicians to incorporate mantle cell lymphoma into their differential workup.
Cory Gallivan, Ali Akbar
doaj   +1 more source

A Rare Case of Severe Lactic Acidosis in a Patient With Mantle Cell Lymphoma

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2021
Lactic acidosis is an extremely rare paraneoplastic manifestation of hematological malignancies, and often carries an extremely poor prognosis. Mantle cell lymphoma is an aggressive and rare form of non-Hodgkin lymphoma.
Kok Hoe Chan MD   +5 more
doaj   +1 more source

Non-Nodal CD5-Negative Mantle Cell Lymphoma with Secondary TP53 Deletion

open access: yesCase Reports in Hematology, 2020
Mantle cell lymphoma is a non-Hodgkin lymphoproliferative neoplasm with several clinical and morphologic variants linked, primarily, through genetic derangement of the cyclin D1 locus.
Robert K. McCall   +2 more
doaj   +1 more source

Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions – case report and review of literature

open access: yesWorld Journal of Surgical Oncology, 2009
Background Mantle cell lymphoma (MCL) is an aggressive type of B-cell non-Hodgkin's lymphoma that originates from small to medium sized lymphocytes located in the mantle zone of the lymph node. Extra nodal involvement is present in the majority of cases,
Abo Stephen M   +6 more
doaj   +1 more source

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma. [PDF]

open access: yesPLoS ONE, 2012
Mantle cell lymphoma is characterized by a genetic translocation results in aberrant overexpression of the CCND1 gene, which encodes cyclin D1. This protein functions as a regulator of the cell cycle progression, hence is considered to play an important ...
Shiri Weinstein   +8 more
doaj   +1 more source

Acalabrutinib for mantle cell lymphoma [PDF]

open access: yesBlood, 2019
AbstractMantle cell lymphoma (MCL) is a unique type of non-Hodgkin lymphoma characterized by the overexpression of cyclin D1. MCL patients typically live for years but experience multiple relapses. Acalabrutinib is a novel second-generation oral Bruton tyrosine kinase inhibitor approved by the US Food and Drug Administration for relapsed MCL based on a
David Inwards, Thomas E. Witzig
openaire   +2 more sources

Home - About - Disclaimer - Privacy